Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263793 · ClinicalTrials.gov registry record · NA
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03263793 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 18 participants.
The verdict
NCT03263793, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The overall goal of this T2 translational research project is to pilot an interdisciplinary high-intensity group singing program to improve speech and swallowing in patients with Parkinson's Disease (PD) and to explore the impact of this program on quality of life (QOL). This research has three specific aims: 1) Determine the effects of a high-intensity group vocal training program on vocal function and laryngeal structure; 2) Determine the transference of vocal training to laryngeal aspects of swallowing; 3) Determine the effect of patient-reported changes in Quality of Life (QOL) as the result of participation in a group vocal training program. Twenty patients with Parkinson Disease will be recruited from the Fresco Institute for Parkinson's \& Movement Disorders to participate in a 12-week vocal training program. The program will train participants using maximum vocal function exercises targeting vocal deficits specific to PD. Choral singing therapy sessions will be conducted once weekly with daily home practice exercises based on principles that have been successful in other intensive PD vocal exercise programs.
Interventions
- BEHAVIORAL Choral (group) singing therapy sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2017-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263793
The ClinicalTrials.gov registry entry for NCT03263793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Choral (group) singing therapy sessions is the first listed.
NCT03263793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263793 about?
NCT03263793 is a clinical study titled "High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease". The overall goal of this T2 translational research project is to pilot an interdisciplinary high-intensity group singing program to improve speech and swallowing in patients with Parkinson's Disease (PD) and to explore the impact of this program on quality of life (QOL). This research has three spec...
What is the current status of trial NCT03263793?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2017-08-22. Estimated completion is 2017-12-13.
What interventions are being tested in trial NCT03263793?
The interventions under investigation include: Choral (group) singing therapy sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03263793?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.